These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31088322)

  • 1. Oral delivery system for low molecular weight protamine-dextran-poly(lactic-co-glycolic acid) carrying exenatide to overcome the mucus barrier and improve intestinal targeting efficiency.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Zhang X; Sun K
    Nanomedicine (Lond); 2019 Apr; 14(8):989-1009. PubMed ID: 31088322
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of CSK-DEX-PLGA Nanoparticles for the Oral Delivery of Exenatide to Improve Its Mucus Penetration and Intestinal Absorption.
    Song Y; Shi Y; Zhang L; Hu H; Zhang C; Yin M; Chu L; Yan X; Zhao M; Zhang X; Mu H; Sun K
    Mol Pharm; 2019 Feb; 16(2):518-532. PubMed ID: 30601014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of low molecular weight protamine to enhance oral absorption of exenatide.
    Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y
    Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tf ligand-receptor-mediated exenatide-Zn
    Zhang L; Shi Y; Song Y; Duan D; Zhang X; Sun K; Li Y
    J Drug Target; 2018 Dec; 26(10):931-940. PubMed ID: 29619854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally administered intelligent self-ablating nanoparticles: a new approach to improve drug cellular uptake and intestinal absorption.
    Liang Y; Ding R; Wang H; Liu L; He J; Tao Y; Zhao Z; Zhang J; Wang A; Sun K; Li Y; Shi Y
    Drug Deliv; 2022 Dec; 29(1):305-315. PubMed ID: 35037529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
    Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
    J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-molecular-weight protamine-modified PLGA nanoparticles for overcoming drug-resistant breast cancer.
    Wang H; Zhao Y; Wang H; Gong J; He H; Shin MC; Yang VC; Huang Y
    J Control Release; 2014 Oct; 192():47-56. PubMed ID: 25003794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextran-protamine coated nanostructured lipid carriers as mucus-penetrating nanoparticles for lipophilic drugs.
    Beloqui A; Solinís MÁ; des Rieux A; Préat V; Rodríguez-Gascón A
    Int J Pharm; 2014 Jul; 468(1-2):105-11. PubMed ID: 24746410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exenatide-loaded inside-porous poly(lactic-co-glycolic acid) microspheres as a long-acting drug delivery system with improved release characteristics.
    Zhai J; Ou Z; Zhong L; Wang YE; Cao LP; Guan S
    Drug Deliv; 2020 Nov; 27(1):1667-1675. PubMed ID: 33241694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles.
    Jaradat A; Macedo MH; Sousa F; Arkill K; Alexander C; Aylott J; Sarmento B
    Int J Pharm; 2020 Jul; 585():119516. PubMed ID: 32525079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved oral absorption of exenatide using an original nanoencapsulation and microencapsulation approach.
    Soudry-Kochavi L; Naraykin N; Nassar T; Benita S
    J Control Release; 2015 Nov; 217():202-10. PubMed ID: 26381898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: In vitro and in vivo evaluation.
    Alibolandi M; Alabdollah F; Sadeghi F; Mohammadi M; Abnous K; Ramezani M; Hadizadeh F
    J Control Release; 2016 Apr; 227():58-70. PubMed ID: 26907831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
    Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
    J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Statistical Optimization of Poly (Lactic-Co-Glycolic Acid) Nanoparticles Encapsulating GLP1 Analog Designed for Oral Delivery.
    Ismail R; Sovány T; Gácsi A; Ambrus R; Katona G; Imre N; Csóka I
    Pharm Res; 2019 May; 36(7):99. PubMed ID: 31087188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uniform carboxymethyl chitosan-enveloped Pluronic F68/poly(lactic-co-glycolic acid) nano-vehicles for facilitated oral delivery of gefitinib, a poorly soluble antitumor compound.
    Wang J; Wang F; Li X; Zhou Y; Wang H; Zhang Y
    Colloids Surf B Biointerfaces; 2019 May; 177():425-432. PubMed ID: 30798063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation, characterization, and pharmacodynamics of exenatide-loaded poly(DL-lactic-co-glycolic acid) microspheres.
    Liu B; Dong Q; Wang M; Shi L; Wu Y; Yu X; Shi Y; Shan Y; Jiang C; Zhang X; Gu T; Chen Y; Kong W
    Chem Pharm Bull (Tokyo); 2010 Nov; 58(11):1474-9. PubMed ID: 21048339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utilization of PLGA nanoparticles in yeast cell wall particle system for oral targeted delivery of exenatide to improve its hypoglycemic efficacy.
    Ren T; Zheng X; Bai R; Yang Y; Jian L
    Int J Pharm; 2021 May; 601():120583. PubMed ID: 33839225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and performance of exendin-4-loaded chitosan-PLGA microspheres for enhancing implant osseointegration in type 2 diabetic rats.
    Shi S; Song S; Liu X; Zhao G; Ding F; Zhao W; Zhang S; Song Y; Ma W
    Drug Deliv; 2022 Dec; 29(1):548-560. PubMed ID: 35156499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability.
    Liu C; Zhang S; McClements DJ; Wang D; Xu Y
    J Agric Food Chem; 2019 May; 67(18):5113-5121. PubMed ID: 31013074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.